- INTANGIBLE COSTING
- Published:
Can we objectively measure the human cost of disease?
The Journal of Headache and Pain volume 4, pages s26–s30 (2003)
Abstract
Economic evaluation of health care programs or technologies requires distinguishing three types of costs: direct, indirect and human. The first two types do not imply peculiar methodological issues to quantify them, even though all researchers do not accept the use of a market prices system. Excluding such different views to calculate in monetary terms these items, evaluation of direct and indirect costs is quite objective. Discussing human costs expressed in quantitative and qualitative terms, we note that they have to be meant as subjective costs. Nevertheless, researchers created health indicators such as QALYs and DALYs, often used in health care studies. Their subjective characteristics require more theoretical discussions about some issues such as the meaning of “quality of life” and “utility”. The lack of a general acceptance of these indicators does not permit their use in health care policy decisions.
Author information
Authors and Affiliations
Additional information
Correspondence to F. Palazzo
Rights and permissions
About this article
Cite this article
Palazzo, F., Stirparo, G. & Terranova, L. Can we objectively measure the human cost of disease?. J Headache Pain 4 (Suppl 1), s26–s30 (2003). https://doi.org/10.1007/s101940300005
Issue Date:
DOI: https://doi.org/10.1007/s101940300005